Wednesday, June 10, 2026

pharma · Plaque Psoriasis · Diabetic Macular Edema

Bausch + Lomb

Bausch + Lomb patent portfolio — 25 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Rochester, IN HQ
1853 Founded
38 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Rochester, IN
Founded
1853
Employees
38
Programs
3
Drugs
5
Patents
25
Intelligence · Patents

Bausch + Lomb patents

25 pharmaceutical patents indexed for Bausch + Lomb. 0 expire within 24 months.

Bausch + Lomb has 25 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. US 2020339710

    GLYCOPHOSPHOLIPID POLYMERIC NETWORK AND USE THEREOF

    Expires Wed Oct 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 2020239601

    CROSSLINKED POLYMERIC NETWORK AND USE THEREOF

    Expires Wed Jul 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 2019151500

    OPHTHALMIC VISCOELASTIC COMPOSITIONS

    Expires Wed May 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. CA 3043000

    DERIVES DE PROSTAGLANDINE LIBERANT DE L'OXYDE NITRIQUE POUR LE TRAITEMENT DU GLAUCOME A TENSION NORMALE

    Expires Wed May 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 2016213609

    OPHTHALMIC SUSPENSION COMPOSITION

    Expires Wed Jul 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 2015038439

    METHOD FOR PREPARING SUSPENSIONS OF LOW-SOLUBILITY MATERIALS

    Expires Wed Jan 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 2014206764

    Poly(Nitrogen/Amine) Derivatives of a Natural Wax and Ophthalmic Compositions

    Expires Wed Jul 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 2014142182

    Aqueous Liquid Composition Containing 2-Amino-3-(4-Bromobenzoyl)Phenylacetic Acid

    Expires Wed May 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. CA 2883399

    REDUCTION AU MINIMUM DE DEPOTS LIPIDIQUES BIOLOGIQUES SUR DES LENTILLES DE CONTACT

    Expires Wed Apr 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. CA 2881745

    COMPOSITIONS OPHTALMIQUES CONTENANT DES ACIDES GRAS OMEGA -3

    Expires Wed Mar 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. WO 2013169458

    COMPOSITIONS PHARMACEUTIQUES ET MÉTHODES DE TRAITEMENT, DE CONTRÔLE, D'AMÉLIORATION, OU D'INVERSION DES TROUBLES DE LA KÉRATOCONJONCTIVITE SÈCHE

    Expires Wed Nov 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 2013289070

    Use of Levocabastine for Modulating Generation of Pro-Inflammatory Cytokines

    Expires Wed Oct 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. WO 2013133980

    DÉRIVÉS NITROXY DE STÉROÏDES DOUX

    Expires Wed Sep 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. WO 2013126156

    COMPOSÉS AGONISTES DE RÉCEPTEURS DE GLUCOCORTICOÏDES SÉLECTIFS DONNEURS D'OXYDE NITRIQUE ET COMPOSITIONS OPHTALMIQUES

    Expires Wed Aug 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. CA 2864833

    COMPOSITIONS OPHTALMIQUES COMPRENANT DES CIRES NATURELLES ALCOXYLEES

    Expires Wed Aug 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 2013210912

    Ophthalmic Pharmaceutical Compositions and Methods of Making and Using Same

    Expires Wed Aug 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. EP 2624836

    BEPOTASTIN-ZUSAMMENSETZUNG

    Expires Tue Aug 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. CA 2852995

    COMPOSITION OPHTALMIQUE QUI CONTIENT DU BROMFENAC PRESENTANT UNE BIODISPONIBILITE ACCRUE

    Expires Wed Apr 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. CA 2851492

    COMPOSITIONS OPHTALMIQUES EN GEL

    Expires Wed Mar 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 2013023492

    PHARMACEUTICAL COMPOSITIONS COMPRISING PLANT-BASED POLYSACCHARIDES AND USES THEREOF

    Expires Wed Jan 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. CA 2838876

    COMPOSITIONS ET PROCEDES DE TRAITEMENT, DE SUPPRESSION, DE REDUCTION OU D'AMELIORATION D'UNE DOULEUR INFLAMMATOIRE

    Expires Wed Dec 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. US 8324171

    Ophthalmic compositions containing diglycine

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. US 2012255544

    BEPOTASTINE COMPOSITIONS

    Expires Wed Oct 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. WO 2012039887

    COMPOSITION ET MÉTHODE ACCÉLÉRANT LA CICATRISATION DES PLAIES

    Expires Wed Mar 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. WO 2011162951

    COMPOSITIONS ET PROCÉDÉS D'AMÉLIORATION DE LA RÉDUCTION D'UN MICRO-ORGANISME SPOROGÈNE

    Expires Wed Dec 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Bausch + Lomb have?

25 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Bausch + Lomb patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.